Immunotherapy combo shows promise before lung surgery
NCT ID NCT05577702
First seen Feb 13, 2026 · Last updated May 14, 2026 · Updated 8 times
Summary
This study tested giving the immunotherapy drug tislelizumab, alone or with other treatments, before surgery for stage II to IIIA non-small cell lung cancer. The goal was to see if these treatments could shrink tumors and improve outcomes. 121 adults participated, and the main measure was how many had a major response in their tumor tissue after treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anyang Cancer Hospital
Anyang, Henan, 455001, China
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, 350001, China
-
Hubei Cancer Hospital
Wuhan, Hubei, 430079, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Hwa Mei Hospital, University of Chinese Academy of Sciences (Ningbo No Hospital)
Ningbo, Zhejiang, 315000, China
-
Liaoning Cancer Hospital and Institute
Shenyang, Liaoning, 110042, China
-
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200025, China
-
Shandong Cancer Hospital
Jinan, Shandong, 250117, China
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200433, China
-
The First Affiliated Hospital of Guangzhou Medical Universitydatansha Hospital)
Guangzhou, Guangdong, 510140, China
-
The First Affiliated Hospital of Nanchang University Branch Xianghu
Nanchang, Jiangxi, 332000, China
-
The First Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, 241001, China
-
The Tumor Hospital Affiliated to Guangxi Medical University
Nanning, Guangxi, 530021, China
Conditions
Explore the condition pages connected to this study.